Friedl-Naderer Johanna (CIK 0001915598)

Latest company ownership

Shares held
148,518
Last filed at
Mar 7, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q1 2025Q4
Role: Chief Commercial Officer
Shares held
94,873
Last filed at
Dec 5, 2025
Confidence Score
52.7
2025Q4
Confidence Score History
2025Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 5, 2025 Dec 5, 2025 Dyne Therapeutics, Inc. Chief Commercial Officer Sell 55.0 -144 -0.15% $3K
Sep 4, 2025 Sep 8, 2025 Dyne Therapeutics, Inc. Chief Commercial Officer Sell 48.8 -1,038 -1.08% $13.8K
Jun 5, 2025 Jun 6, 2025 Dyne Therapeutics, Inc. Chief Commercial Officer Sell 55.0 -146 -0.15% $1.9K
Mar 13, 2025 Mar 13, 2025 Dyne Therapeutics, Inc. Chief Commercial Officer Sell 55.0 -143 -0.15% $1.7K
Mar 3, 2023 Mar 7, 2023 Vir Biotechnology, Inc. COO Sell 48.8 -1,482 -0.99% $33.8K